Systematic Review and Pharmacological Considerations for Chloroquine and Its Analogs in the Treatment for COVID-19

• Main Authors: Hongwei Peng (Author), Zhangren Chen (Author), Yunyun Wang (Author), Simei Ren (Author), Tiantian Xu (Author), Xin Lai (Author), Jinhua Wen (Author), Mengjun Zhao (Author), Chuanfei Zeng (Author), Lijuan Du (Author), Yanmei Zhang (Author), Li Cao (Author), Jinfang Hu (Author), Xiaohua Wei (Author), Tao Hong (Author)
• Format: Book
• Published: Frontiers Media S.A., 2020-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

COVID-19 has been announced pandemic by WHO and over 17,000,000 people infected (Till April 21st 2020). The disease is currently under control in China, with a curative rate of 86.8%. Chloroquine (CQ) is an old anti-malarial drug with good tolerability, which had proved to be effective in previous S...